Press Releases July 7, 2026 08:00 AM

GrowGeneration Joins the U.S. Cannabis Roundtable to Help Shape the Future of America’s Cannabis Industry

GrowGeneration joins U.S. Cannabis Roundtable to influence cannabis industry policy amid federal regulatory shifts

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
GRWG

GrowGeneration Corp., a leading supplier of specialty products for controlled environment agriculture and commercial cultivation, announced its membership in the U.S. Cannabis Roundtable (USCR), a prominent organization advocating for federal cannabis reform. The company's CEO highlighted recent federal developments, including the potential reclassification of state-licensed medical cannabis to Schedule III, which could offer tax relief to operators and benefit GrowGeneration's customers by enabling further investment in cultivation infrastructure.

GrowGeneration Joins the U.S. Cannabis Roundtable to Help Shape the Future of America’s Cannabis Industry
GRWG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • GrowGeneration joins the U.S. Cannabis Roundtable to participate in shaping federal cannabis regulation.
  • The company is positioned to benefit from federal reforms, including potential 280E tax relief for cannabis operators.
  • GrowGeneration provides essential products and infrastructure solutions to cannabis cultivators, positioning it well amidst industry growth and regulatory changes.

DENVER, Colo., July 07, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGeneration,” “GrowGen” or “the Company”), one of the nation’s largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and garden centers, today announced its membership in the U.S. Cannabis Roundtable (USCR), one of the nation’s leading policy organizations shaping the future of cannabis regulation. GrowGeneration will be represented in USCR by its Chief Executive Officer and Co-Founder, Darren Lampert.

The U.S. Cannabis Roundtable is among the leading voices in federal cannabis reform, bringing together operators, ancillary service providers, and policy experts to advocate for responsible regulation, financial access, and industry standardization. Its members include the nation’s leading cannabis operators and ancillary businesses and operate in all 41 states where cannabis is legal (medical or adult use).

“We're pleased to welcome GrowGeneration as the newest member of USCR,” said Charlie Bachtell, CEO of Cresco Labs and Chairperson of USCR. “With expertise across both agriculture and cannabis, they are uniquely positioned to complement our members' knowledge and experience. We're looking forward to their contributions as we continue to advocate for commonsense industry regulations.”

“We are honored to join USCR and look forward to working with other industry thought leaders during this pivotal time,” said Mr. Lampert. “The order moving state-licensed medical cannabis to Schedule III of the Controlled Substances Act is a landmark event, providing potential 280E tax relief to qualifying operators. This is a meaningful tailwind for our customers, increasing their capacity to invest in the cultivation infrastructure we provide. We believe GrowGeneration is well positioned to support our customers as the industry continues to mature and evolve.”

About GrowGeneration Corp:

GrowGen is one of the nation’s largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and garden centers. GrowGen carries and sells thousands of products, such as nutrients, additives, growing media, lighting, environmental control systems, and benching and racking, including proprietary brands such as Char Coir, Drip Hydro, Power Si, Ion lights, The Harvest Company, and more. The Company also operates an online superstore for cultivators at growgeneration.com, as well as a wholesale business for resellers, and a benching, racking, and storage solutions business, MMI Storage Solutions.

To be added to the GrowGeneration email distribution list, please email [email protected] with GRWG in the subject line.

Forward Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect opinions only as of the date of this release. Please keep in mind that the Company does not have an obligation to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as “look forward,” “expect,” “believe,” “anticipate,” “estimate,” or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by us herein are often discussed in filings made with the United States Securities and Exchange Commission, available at: www.sec.gov, and on the Company’s website, at: www.growgeneration.com.

Investor Relations:
KCSA Strategic Communications
Philip Carlson, Managing Director
T: 212-896-1233
[email protected]


Risks

  • Federal cannabis regulation and reform remain uncertain and are subject to political and legislative changes, which could impact industry dynamics.
  • Market adoption of regulatory changes like Schedule III reclassification may be delayed or limited, affecting projected benefits for operators and suppliers.
  • Operational risks include dependence on the cannabis industry's growth and potential fluctuations in demand for cultivation products and infrastructure solutions.

More from Press Releases

Treasure Global Launches Exclusive OXI Visa Card Initiative for TGL Shareholders Jul 7, 2026 STEALTHGAS INC. Jul 7, 2026 Gemini Launches Commission-Free Stock Trading In Next Step Toward Financial Super App Jul 7, 2026 Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases Jul 7, 2026 European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process Jul 7, 2026